Vafa Shahabi

2.2k total citations · 1 hit paper
27 papers, 1.8k citations indexed

About

Vafa Shahabi is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, Vafa Shahabi has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 12 papers in Biotechnology. Recurrent topics in Vafa Shahabi's work include Immunotherapy and Immune Responses (11 papers), Cancer Research and Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Vafa Shahabi is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Cancer Research and Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Vafa Shahabi collaborates with scholars based in United States, Sweden and Denmark. Vafa Shahabi's co-authors include David M. Berman, Scott D. Chasalow, Lisu Wang, Maria Jure–Kunkel, Anu Wallecha, Rui‐Ru Ji, Paulo Maciag, Omid Hamid, Suresh Alaparthy and Sandra Rivera and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Vafa Shahabi

27 papers receiving 1.7k citations

Hit Papers

An immune-active tumor microenvironment favors clinical r... 2011 2026 2016 2021 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An immune-active tumor microenvironment favors clinical response to ipilimumab
    2011 593 citations Rui‐Ru Ji, Scott D. Chasalow et al. Cancer Immunology Immunotherapy profile →

Peers

Vafa Shahabi
Theresa J. Goletz United States
S. V. S. Kashmiri United States
Carl E. Ruby United States
Purnima Dubey United States
Marco Bestagno Italy
Karen J. Scott United Kingdom
Maria Ferrantini Italy
Danita H. Schuurhuis Netherlands
Lihua Tao United States
Jens Dannull United States
Theresa J. Goletz United States
Vafa Shahabi
Citations per year, relative to Vafa Shahabi Vafa Shahabi (= 1×) peers Theresa J. Goletz

Countries citing papers authored by Vafa Shahabi

Since Specialization
Citations

This map shows the geographic impact of Vafa Shahabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vafa Shahabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vafa Shahabi more than expected).

Fields of papers citing papers by Vafa Shahabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vafa Shahabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vafa Shahabi. The network helps show where Vafa Shahabi may publish in the future.

Co-authorship network of co-authors of Vafa Shahabi

This figure shows the co-authorship network connecting the top 25 collaborators of Vafa Shahabi. A scholar is included among the top collaborators of Vafa Shahabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vafa Shahabi. Vafa Shahabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahabi, Vafa, David M. Berman, Scott D. Chasalow, et al.. (2013). Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events. Journal of Translational Medicine. 11(1). 75–75. 132 indexed citations
2.
Shahabi, Vafa, Michael A. Postow, David Tuck, & Jedd D. Wolchok. (2013). Immune-priming of the Tumor Microenvironment by Radiotherapy. American Journal of Clinical Oncology. 38(1). 90–97. 74 indexed citations
3.
Shahabi, Vafa, Gena S. Whitney, Omid Hamid, et al.. (2012). Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab. Cancer Immunology Immunotherapy. 61(5). 733–737. 63 indexed citations
4.
Ribas, Antoni, F. Stephen Hodi, John F. Kurland, et al.. (2012). CA184-161: A phase I/II trial of vemurafenib and ipilimumab in patients with BRAF V600 mutation-positive metastatic melanoma.. Journal of Clinical Oncology. 30(15_suppl). TPS8603–TPS8603. 12 indexed citations
5.
Ji, Rui‐Ru, Scott D. Chasalow, Lisu Wang, et al.. (2011). An immune-active tumor microenvironment favors clinical response to ipilimumab. Cancer Immunology Immunotherapy. 61(7). 1019–1031. 593 indexed citations breakdown →
6.
Shahabi, Vafa, Paulo Maciag, Sandra Rivera, & Anu Wallecha. (2010). Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment. PubMed. 1(4). 237–245. 51 indexed citations
7.
Wood, Laurence M., Zhen-Kun Pan, Vafa Shahabi, & Yvonne Paterson. (2010). Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy. Cancer Immunology Immunotherapy. 59(7). 1049–1058. 23 indexed citations
8.
Shahabi, Vafa, Matthew M. Seavey, Paulo Maciag, Sandra Rivera, & Anu Wallecha. (2010). Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human. Cancer Gene Therapy. 18(1). 53–62. 63 indexed citations
9.
Hoos, Axel, Ramy Ibrahim, Alan J. Korman, et al.. (2010). Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy. Seminars in Oncology. 37(5). 533–546. 196 indexed citations
10.
Ishizaki, Hidenobu, Tumul Srivastava, Kyla Driscoll Carroll, et al.. (2010). Heterologous Prime/Boost Immunization With p53-based Vaccines Combined With Toll-like Receptor Stimulation Enhances Tumor Regression. Journal of Immunotherapy. 33(6). 609–617. 25 indexed citations
11.
12.
Wallecha, Anu, Kyla Driscoll Carroll, Paulo Maciag, et al.. (2009). Chapter 1 Multiple Effector Mechanisms Induced by Recombinant Listeria monocytogenes Anticancer Immunotherapeutics. Advances in applied microbiology. 66. 1–27. 20 indexed citations
13.
Shahabi, Vafa, et al.. (2008). Development of a Listeria monocytogenes based vaccine against prostate cancer. Cancer Immunology Immunotherapy. 57(9). 1301–1313. 79 indexed citations
14.
Periwal, S. Bhargava, et al.. (2005). Statistical evaluation for detection of peptide specific interferon-γ secreting T-cells induced by HIV vaccine determined by ELISPOT assay. Journal of Immunological Methods. 305(2). 128–134. 4 indexed citations
15.
16.
Cassetti, M. Cristina, Vafa Shahabi, Jeffrey K. Pullen, et al.. (2003). Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes. Vaccine. 22(3-4). 520–527. 101 indexed citations
17.
Shahabi, Vafa. (1999). Transport Pathways for Therapeutic Concentrations of Lithium in Rat Liver. The Journal of Membrane Biology. 172(2). 101–111. 1 indexed citations
18.
Chen, Chongguang, Vafa Shahabi, Wei Xu, & Lee‐Yuan Liu‐Chen. (1998). Palmitoylation of the rat μ opioid receptor. FEBS Letters. 441(1). 148–152. 23 indexed citations
19.
Bäckström, Malin, Vafa Shahabi, Susann Teneberg, et al.. (1997). Structural basis for differential receptor binding of cholera and Escherichia coli heat‐labile toxins: influence of heterologous amino acid substitutions in the cholera B‐subunit. Molecular Microbiology. 24(3). 489–497. 27 indexed citations
20.
Lebens, Michael, et al.. (1996). Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine. Infection and Immunity. 64(6). 2144–2150. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa J. Goletz Breakdown of academic impact, for papers by S. V. S. Kashmiri Breakdown of academic impact, for papers by Carl E. Ruby Breakdown of academic impact, for papers by Purnima Dubey Breakdown of academic impact, for papers by Marco Bestagno Breakdown of academic impact, for papers by Karen J. Scott Breakdown of academic impact, for papers by Maria Ferrantini Breakdown of academic impact, for papers by Danita H. Schuurhuis Breakdown of academic impact, for papers by Lihua Tao Breakdown of academic impact, for papers by Jens Dannull
Rankless by CCL
2026